Login
$ALDX
$0.67 +$0.03 (4.01%) Live

Ownership

13F as of Q2 2026 · 60.4M shares outstanding

Who owns ALDX?

By type of holder
Institutions 60.4% Insiders 17.9% Everyone else 21.7%
Concentration Top 10 holders own 38.9%
Knoll Capital Management, LLC 9.1% · BlackRock, Inc. 2.1%
Institutional ownership
60.4%
-1.4 pts vs last qtr
Institutional holders
106
-22 vs last qtr
Net shares bought
−871.7K
by institutions in Q2 2026
New / sold out
19 / 41
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Marshall Wace, LLP +1.4M
  • Qube Research & Technologies Ltd +1.0M

Sign up to see all 5.

Biggest sellers in Q2 2026
  • BlackRock, Inc. −2.5M
  • State Street Corp −890.9K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Aldeyra Therapeutics, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2016–FY2025
+429.0%
+20.33% a year
Each share's claim on the business
−81.1%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $60M
over 10 fiscal years
Diluted shares, split-adjusted
11.0M35.8M60.7M2016: 11.4M shares'162017: 15.9M shares'172018: 21.7M shares'182019: 27.1M shares'192020: 34.0M shares'202021: 54.0M shares'212022: 58.4M shares'222023: 58.9M shares'232024: 59.5M shares'242025: 60.1M shares'25
Buybacks Stock-based comp
$0$4.1M$8.3M2016 buybacks: $02016 stock comp: $2.8M'162017 buybacks: $02017 stock comp: $2.7M'172018 buybacks: $02018 stock comp: $4.1M'182019 buybacks: $02019 stock comp: $8.1M'192020 buybacks: $02020 stock comp: $7.1M'202021 buybacks: $02021 stock comp: $7.1M'212022 buybacks: $02022 stock comp: $8.3M'222023 buybacks: $02023 stock comp: $5.8M'232024 buybacks: $02024 stock comp: $8.0M'242025 buybacks: $02025 stock comp: $6.1M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years44% 3–5 years4% 1–3 years37% Under 1 year15%
Quarterly turnover
22.2%
of institutional shares changed hands
Top 10 managers, median time held
1.5 years

Super Investors

Investment managers reporting ALDX on Form 13F
KC
Knoll Capital Management, LLC
Shares
5.5M
% of company
9.07%
Change vs last qtr
Unchanged
Held since
≤2021
B
BlackRock, Inc.
Shares
1.3M
% of company
2.08%
Change vs last qtr
−2.5M (−66.6%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding Aldeyra Therapeutics, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting ALDX on Form N-PORT; together they hold 13.7% of the company
VT
Position value
$3.8M
% of company
2.96%
% of the fund
0.00%
As of
June 30, 2026
IR
iShares Trust
Position value
$2.32M
% of company
2.28%
% of the fund
0.00%
As of
March 31, 2026

23 more funds behind a free account

See every fund holding Aldeyra Therapeutics, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
BT
Brady Todd C
Insider
Shares
1.7M
% of company
2.85%
Change vs last qtr
—
Held since
—
DR
Douglas Richard
Insider
Shares
395.0K
% of company
0.65%
Change vs last qtr
—
Held since
—

2 more holders behind a free account

See every insider and 5%+ holder of Aldeyra Therapeutics, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support